TD Cowen on OrthoPediatrics Corp. (KIDS): 'An Underappreciated Growth Story w/ Profitability Inflecting'

TD Cowen analyst Michael Blackman reiterated a Buy rating and $23.00 price target on OrthoPediatrics Corp. (NASDAQ: KIDS).

The analyst commented: "An Underappreciated Growth Story w/ Profitability Inflecting; Last week, we hosted KIDS CEO David Bailey & CFO Fred Hite for meetings. We recap 4 themes: the new product "Supercycle", how KIDS is governing growth for cash/profitability, but highlighting a long revenue runway and thoughts on the market with large competitors exiting, opening opportunities. We think the KIDS growth & profitability inflection story remains underappreciated/undervalued."

For an analyst ratings summary and ratings history on OrthoPediatrics Corp. click here. For more ratings news on OrthoPediatrics Corp. click here.

Shares of OrthoPediatrics Corp. closed at $17.82 yesterday.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Air T reports revenue jump but widens operating loss in Q1 fiscal 2027